Despite reports on platelet involvement with leukocytes and cytokines in type II inflammation (i.e. IL-33 expression and modulation of eosinophils25, platelet-eosinophil interaction26), no distinct type II-phenotype was apparent in the investigated AD cohorts. This evidence concerns the gene IL33 and Alzheimer disease.